Search

Search Constraints

You searched for: Author/Creator Barsan, Valentin

Search Results

1. 75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer. (10th December 2020)

2. Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Issue 1 (4th July 2019)

3. DIPG-15. Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T-cells. (3rd June 2022)

4. EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. (1st June 2021)

5. IMMU-10. NIVOLUMAB IN THE TREATMENT OF RECURRENT OR REFRACTORY PEDIATRIC BRAIN TUMORS: A SINGLE INSTITUTIONAL EXPERIENCE. Issue 2 (22nd June 2018)

7. Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience. Issue 4 (May 2019)

8. OMIC-11. SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+ DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY. (1st June 2021)

9. P854 Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets. (15th April 2020)